Drawing for ELVERA

USPTO serial 79227985

ELVERA

Reviewed by CopyMark Law Group

Reg. 5736037Status 709
Filing date
Status date
Registration date
Apr 30, 2019
Examiner
MAZZELLA, BRANDY BARRETT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ELVERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Donna J. Bunton

Donna J. Bunton NIXON & VANDERHYE P.C.901 North Glebe Road, 11th FloorArlington, VA 22203UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical and pharmaceutical preparations in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; medical drugs for human use for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; dietetic and nutritional preparations and substances in the form of foods and beverages adapted for medical use; protein pharmaceuticals in the field of human medicine for the prevention and treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified chemical compounds for medical purposes, namely, for the treatment of diseases and conditions in the therapeutic areas of hematology, inflammation, genetics and metabolism; modified protein arrays for medical use in the therapeutic areas of hematology, inflammation, genetics and metabolism; none of the aforementioned goods being cosmetic skin care preparations and cosmeticsSECTION 71 - CANCELLED—
042Research and development of pharmaceuticals, protein pharmaceuticals, biological pharmaceuticals, proteins, protein structures, chemical modification of substances, compounds for efficient effect of drugs, compounds for controlled release of pharmaceutical substances within the pharmaceutical field; none of the aforementioned being cosmetic researchSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 14, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 14, 2025C71TCANCELLED SECTION 71—
Apr 30, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 16, 2021LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 20, 2020LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 20, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 6, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 16, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 15, 2019FIMPFINAL DISPOSITION PROCESSED—
Jul 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 8, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 23, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 23, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 23, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 3, 2019LIMELIMITATION FROM THE IB - REQUEST EXAM REVIEW—
Dec 28, 2018LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 27, 2018RFNTREFUSAL PROCESSED BY IB—
Apr 9, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 9, 2018RFRRREFUSAL PROCESSED BY MPU—
Apr 3, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 2, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2018DOCKASSIGNED TO EXAMINER—
Mar 10, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 1, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance